The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Beta-Blockers for Migraines

Published Online:https://doi.org/10.1176/pn.37.18.0026d

Thanks for the review of migraines in the July 5 issue. I disagree on one point: The article states that beta-blockers should not be used in people with depression. The July 17 issue of the Journal of the American Medical Association carried an excellent review of beta-blockers and symptoms of depression, fatigue, and sexual dysfunction. The authors stated that there is no substantial risk of depression, and only a small risk of fatigue and sexual dysfunction. This finding fits with what I have observed in my practice for more than 15 years.

Editor’s note: The JAMA article referenced above is a review of clinical trial data. Postmarketing data have associated beta-blockers with an increased incidence of depression.

Plano, Tex.